biosimilars

biosimilars

美 　英

• 网络生物仿制药；生物相似药；生技仿制药

例句

And he supports efforts to encourage "biosimilars" , a form of generic rival to biotech drugs, which the industry hates.

同时，不顾制药业的反对，麦凯恩还鼓励研制生物仿制药——这种基因药物是生化药物的竞争对手。

It will spend about half of the 2. 1 trillion won budget on developing biosimilars and use the other half to build factories, he said.

他说，三星集团将花费2100万韩元投资中的一般用于开发生物仿制药，而另一半用于建设生产厂。

There's a lot of talk about biosimilars but from my view there will also be a lot of wait-and-see.

有关生物仿制药品的传言甚多，但在我看来，许多都是在观望。

Biosimilars are generic impersonations (although not identical copies) of biotech drugs.

生物仿制制药是对生物技术制药进行的非专利仿制（尽管不是完全一致的复制）。

It is actually a very cost-efficient way for pharma companies to differentiate themselves from the biosimilars.

对于制药公司来说，这可以很划算地让他们与一般的生物仿制药作出区分。

This is part of a new strategy to become a "one-stop shop" for biosimilars, explains David Simmons of Pfizer.

来自辉瑞制药的戴维西蒙斯说这是组成生物仿制制药“一站式商店”这个新战略的一部分。

Cipla, an Indian generics maker, and China's Desano Pharma are also getting into the biosimilars business.

印度非专利药品厂商Cipla和中国迪赛诺医药发展有限公司也正在进入仿生物药品业务。

Samsung Group may also set up another joint venture to make biosimilars this year, Kim said.

金泰韩说，三星集团今年还会再成立一家合资公司生产生物仿制药。

First, they are much harder to copy, so generic equivalents (called "biosimilars" ) will be slow in coming.

首先，该行业技术更难效仿，通用一个药名的制剂（生物仿制药）很难出现。

Biosimilars are a hot new area.

仿生物药品是新型热门领域。